Effect of intravenous iron in the treatment of chronic iron deficiency anemia in colon cancer patients

Comparing the effectiveness of ferric carboxymaltose and oral iron in treatment of chronic iron deficiency anemia in colon cancer patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015092111560N9

Enrollment

Registered

2015-12-12

Start date

2015-07-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anaemia. Iron deficiency anaemia

Interventions

Intervention 1: 1500 mg bolus injection of ferric carboxymaltose (Injectafer®). Intervention 2: 65mg/TDS ferrous sulfate (Daru Yab. Co) until two month, 180 tables.

Treatment - Drugs

1500 mg bolus injection of ferric carboxymaltose (Injectafer®)

65mg/TDS ferrous sulfate (Daru Yab. Co) until two month, 180 tables

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria : colon cancer; chronic iron deficiency anemia. Exclusion criteria: severe drug reaction; lost to follow up; low level of consciousness due to underlying disease and death.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemiglobin. Timepoint: Pre treatment; 8 weeks following end of treatment. Method of measurement: gram/ deciliter using of blood sample.;Ferritin. Timepoint: Pre treatment; 8 weeks following end of treatment. Method of measurement: nanogram/ mililiter using of blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNaffiseh Ansarinejad

Iran University of Medical Sciences

slr_1975@yahoo.com+98 21 6631 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026